Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 892 | 105 | -172 | 362 | 1,035 |
| Depreciation Amortization | 1,059 | 663 | 317 | 1,184 | 881 |
| Accounts receivable | -1,693 | -1,321 | -825 | -2,265 | -1,401 |
| Accounts payable and accrued liabilities | 1,772 | 1,506 | 1,372 | -1,246 | -1,395 |
| Other Working Capital | 2,363 | -370 | -528 | -4,197 | -2,254 |
| Other Operating Activity | 1,308 | 861 | 52 | 4,481 | 3,433 |
| Operating Cash Flow | $5,701 | $1,444 | $216 | $-1,681 | $299 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,878 | -1,473 | -907 | -3,281 | -2,427 |
| Other Investing Activity | 0 | 0 | 0 | 112 | 92 |
| Investing Cash Flow | $-1,878 | $-1,473 | $-907 | $-3,169 | $-2,335 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -174 | -173 |
| Common Stock Issued | 191 | 123 | 2 | 1,369 | 1,296 |
| Financing Cash Flow | $191 | $123 | $2 | $1,195 | $1,123 |
| Beginning Cash Position | 4,687 | 4,687 | 4,687 | 8,342 | 8,342 |
| End Cash Position | 8,701 | 4,781 | 3,998 | 4,687 | 7,429 |
| Net Cash Flow | $4,014 | $94 | $-689 | $-3,655 | $-913 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,701 | 1,444 | 216 | -1,681 | 299 |
| Capital Expenditure | -1,878 | -1,473 | -907 | -3,281 | -2,427 |
| Free Cash Flow | 3,823 | -29 | -691 | -4,962 | -2,128 |